Transdermal patches, sublingual medications, and inhaled agents are similarly unaffected
Novos GLP-1 revenue generated around $35 billion in 2025, about 75% of the companys annual revenue
In one study, the average semaglutide patient lost over 10% of their body weight (e.g
These experiences, while not universal, suggest that the refund process could be more patient-friendly
For women experiencing gastrointestinal symptoms whilst taking GLP-1 medications, probiotics may offer supportive benefits, though it is important to note that there is no official link established between specific probiotic strains and improved outcomes in GLP-1 users
Among the exendin 939 fragments, exendin 2029 specifically binds to TRPV1, alleviating pain in both acute and chronic pain models without interfering with GLP-1R function